These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 12877730

  • 1. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
    Chou YY, Jeng YM, Kao HL, Chen T, Mao TL, Lin MC.
    Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
    Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ.
    Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
    [Abstract] [Full Text] [Related]

  • 3. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.
    Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM.
    Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188
    [Abstract] [Full Text] [Related]

  • 4. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
    Porjazova E, Zaprjanov Z, Batashki I, Markova D, Milchev N.
    Akush Ginekol (Sofiia); 2009 Oct; 48(2):7-12. PubMed ID: 20198769
    [Abstract] [Full Text] [Related]

  • 5. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.
    Logani S, Oliva E, Arnell PM, Amin MB, Young RH.
    Mod Pathol; 2005 Jan; 18(1):19-25. PubMed ID: 15389251
    [Abstract] [Full Text] [Related]

  • 6. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [Abstract] [Full Text] [Related]

  • 7. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ.
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [Abstract] [Full Text] [Related]

  • 8. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.
    Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL.
    Clin Cancer Res; 2004 Feb 15; 10(4):1401-8. PubMed ID: 14977843
    [Abstract] [Full Text] [Related]

  • 9. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
    Loy TS, Calaluce RD, Keeney GL.
    Mod Pathol; 1996 Nov 15; 9(11):1040-4. PubMed ID: 8933513
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S, Wasserman JK, Giassi A, Djordjevic B, Parra-Herran C.
    Int J Gynecol Pathol; 2016 May 15; 35(3):191-208. PubMed ID: 26535987
    [Abstract] [Full Text] [Related]

  • 11. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.
    Am J Surg Pathol; 2016 Mar 15; 40(3):419-32. PubMed ID: 26551622
    [Abstract] [Full Text] [Related]

  • 12. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.
    Diagn Mol Pathol; 2001 Jun 15; 10(2):116-22. PubMed ID: 11385321
    [Abstract] [Full Text] [Related]

  • 13. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta.
    Rask K, Nilsson A, Brännström M, Carlsson P, Hellberg P, Janson PO, Hedin L, Sundfeldt K.
    Br J Cancer; 2003 Oct 06; 89(7):1298-304. PubMed ID: 14520463
    [Abstract] [Full Text] [Related]

  • 14. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN, Badve S, Papreddy K, Schindler S, Laskin WB, Yeldandi AV.
    Hum Pathol; 2002 Sep 06; 33(9):915-20. PubMed ID: 12378517
    [Abstract] [Full Text] [Related]

  • 15. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.
    Jpn J Clin Oncol; 2010 Mar 06; 40(3):208-13. PubMed ID: 19926591
    [Abstract] [Full Text] [Related]

  • 16. CDX-2 immunostaining in primary and secondary ovarian carcinomas.
    Tornillo L, Moch H, Diener PA, Lugli A, Singer G.
    J Clin Pathol; 2004 Jun 06; 57(6):641-3. PubMed ID: 15166272
    [Abstract] [Full Text] [Related]

  • 17. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM, Meir A, Sabo E.
    Int J Gynecol Pathol; 2004 Jan 06; 23(1):52-7. PubMed ID: 14668551
    [Abstract] [Full Text] [Related]

  • 18. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
    Cao D, Ji H, Ronnett BM.
    Int J Gynecol Pathol; 2005 Jan 06; 24(1):67-72. PubMed ID: 15626919
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S, Parra-Herran C.
    Histopathology; 2016 Jun 06; 68(7):977-87. PubMed ID: 26542609
    [Abstract] [Full Text] [Related]

  • 20. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
    Fleuren GJ, Nap M.
    Gynecol Oncol; 1988 Jul 06; 30(3):407-15. PubMed ID: 2839395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.